Burden of chemotherapy-induced neuropathy-a cross-sectional study

Supportive Care in Cancer

Volumn 19, Issue 12, 2011, Pages 1991-1996

  Kautio, Anna Liisa ^a   Haanpää, Maija ^a,b   Kautiainen, Hannu ^b,c   Kalso, Eija ^a   Saarto, Tiina ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Orton Hospital   (Finland)

^c Central Finland Central Hospital   (Finland)

Author keywords

Adverse effects; Chemotherapy; Neurotoxicity; Peripheral neuropathy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; NAVELBINE; OXALIPLATIN; PACLITAXEL; VINCRISTINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; COHORT ANALYSIS; COLORECTAL CANCER; CONSTIPATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EDEMA; EYE DISEASE; FATIGUE; FEMALE; FOOT PAIN; HAIR LOSS; HAND DISEASE; HAND PAIN; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; MUCOSA INFLAMMATION; MUSCLE WEAKNESS; NATIONAL CANCER INSTITUTE COMMON TOXICITY CRITERIA; NAUSEA; NEUROPATHY; PAIN; PARESTHESIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SENSORY DYSFUNCTION; SENSORY NEUROPATHY; SIDE EFFECT; SKIN TINGLING; SWEATING; TASTE; VISUAL ANALOG SCALE; WALKING DIFFICULTY;

ADULT; ANTINEOPLASTIC AGENTS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 83555163919     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-1043-2     Document Type: Article

References (19)

1. AJ Ocean LT Vahdat 2004 Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies Support Care Cancer 12 619 625 15258838 (Pubitemid 39280311)
2. S Quasthoff HP Hartung 2002 Chemotherapy-induced peripheral neuropathy J Neurol 249 9 17 11954874 10.1007/PL00007853 1:CAS:528:DC%2BD38XisVKkt7k%3D (Pubitemid 34119018)
3. T Winton R Livingston D Johnson, et al. 2005 Vinorelbine plus cisplatin vs. observation in resected non small-cell lung cancer N Engl J Med 352 2589 2597 15972865 10.1056/NEJMoa043623 1:CAS:528:DC%2BD2MXls1Wqurg%3D (Pubitemid 41007845)
4. Albers J,Chaudhry V, Cavaletti G, Donehower R (2007) Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev (1):CD005228. Review
5. N Attal G Cruccu M Haanpää P Hansson TS Jensen T Nurmikko, et al. 2006 EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 13 1153 1169 17038030 10.1111/j.1468-1331.2006.01511.x 1:STN:280:DC%2BD28ngs1Smug%3D%3D (Pubitemid 44581463)
6. JE Hammack JC Michalak CL Loprinzi, et al. 2002 Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Pain 98 195 203 12098632 10.1016/S0304-3959(02)00047-7 1:CAS:528:DC%2BD38XkvFyrsbc%3D (Pubitemid 34722482)
7. A Kautio M Haanpää T Saarto E Kalso 2008 Amitriptylin in the treatment of chemotherapy incuded neuropathic symptoms J Pain Symptom Manage 35 31 39 17980550 10.1016/j.jpainsymman.2007.02.043 1:CAS:528:DC%2BD1cXhslKrsLw%3D (Pubitemid 350299098)
8. RD Rao JC Michalak JA Sloan CL Loprinzi GS Soori DA Nikcevich, et al. 2007 Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy Cancer 110 21110 21118 10.1002/cncr.23008 (Pubitemid 350036873)
9. RD Rao PJ Flynn JA Sloan GY Wong P Novotny DB Johnson, et al. 2008 Efficay of lamotrigine in the management of chemotherapy-induced peripheral neuropathy Cancer 112 2802 2808 18428211 10.1002/cncr.23482 1:CAS:528: DC%2BD1cXosVGgsrY%3D (Pubitemid 351969227)
10. S von Delius F Eckel S Wagenpfeil M Mayr K Stock F Kullmann, et al. 2007 Carbamazepine for prevention of oxaliplatin related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study Invest New Drugs 25 173 180 10.1007/s10637-006-9010-y (Pubitemid 46020877)
11. A Pace L Bove C Nisticò M Ranuzzi P Innocenti A Pietrangeli, et al. 1996 Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients J Neurol Neurosurg Psych 61 409 411 10.1136/jnnp.61.4.409 1:STN:280:DyaK2s%2FksFylsg%3D%3D (Pubitemid 26355786)
12. K Shimozuma Y Ohashi A Takeuchi, et al. 2009 Feasibility and validity of the patient neurotoxicity questionnaire during taxane chemotherapy in a phase II randomized trial in patients with breast cancer: N-SAS BC 02 Support Care Cancer 17 12 1483 1491 19330359 10.1007/s00520-009-0613-7
13. TJ Postma JJ Heimans 2000 Grading chemotherapy-induced peripheral neuropathy Ann Oncol 11 509 513 10907941 10.1023/A:1008345613594 1:STN:280:DC%2BD3M%2Fms1OhsQ%3D%3D (Pubitemid 30431370)
14. V Chaudhry M Chaudhry TO Crawford E Simmons-O'Brien JW Griffin 2003 Toxic neuropathy in patients with pre-existing neuropathy Neurology 60 337 340 12552058 1:STN:280:DC%2BD3s%2FktlWntw%3D%3D (Pubitemid 36152036)
15. SH Sindrup LF Gram K Brøsen O Eshøj EF Mogensen 1990 The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms Pain 42 2 135 144 2147235 10.1016/0304-3959(90) 91157-E 1:STN:280:DyaK3M%2Fmt1Whtg%3D%3D (Pubitemid 20258898)
16. JP Cata HR Weng AW Burton H Villareal S Giralt PM Dougherty 2007 Quantitative sensory findings in patients with bortezomib-induced pain J Pain 8 296 306 17175202 10.1016/j.jpain.2006.09.014 1:CAS:528:DC%2BD2sXktF2gtL4%3D (Pubitemid 46551871)
17. PA Forsyth C Balmaceda K Peterson AD Seidman P Brasher 1997 DeAngelis LM.Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing J Neurooncol 35 47 53 9266440 10.1023/A: 1005805907311 1:STN:280:DyaK2svhtFClsA%3D%3D (Pubitemid 27361845)
18. G Cavaletti G Bogliun L Marzorati A Zincone M Piatti N Colombo G Parma A Lissoni F Fei S Cundari C Zanna 2003 Grading of chemotherapy-induced peripheral neurotoxicity using the total neuropathy scale Neurology 61 1297 1300 14610145 1:CAS:528:DC%2BD3sXpslykurg%3D (Pubitemid 37377562)
19. M Markman 2006 Chemotherapy-induced peripheral neuropathy: underreported and underappreciated Curr Pain Rep 3 154 157